Institution

U.S. Food and Drug Administration

U.S. Food and Drug Administration — US regulator that approved Teva’s schizophrenia treatment Weltruza. Every TV10 Global story that covers or mentions U.S. Food and Drug Administration, translated into English from TV10's Hebrew reporting.

Type
Institution

3 stories on TV10 Global

Breaking

Trading Delayed in Newest Addition to Tel Aviv Flagship Indices

At the company’s request, trading in biomedical company Alpha Tau will open today on the Tel Aviv Stock Exchange (TASE) alongside Nasdaq • An hour before the opening, the company will present investors with interim results from a brain cancer trial • Last month, the FDA approved the trial’s expansion

Sharon Birkman
Teva stock
Above expectations

Teva Reports Revenue of $4.4 Billion

Adjusted gross profit margin soared to a decade high of 58.7% • The company raised its annual revenue forecast following sharp growth in innovative medicines

Shai Nogai
Teva stock
Hit a Record High

FDA Approves New Teva Schizophrenia Treatment — Stock Jumps

Teva received approval from the U.S. Food and Drug Administration to market WELTRUZA, intended for adults • The new treatment is based on the active ingredient olanzapine and is administered as a once-monthly subcutaneous injection without the need for loading doses • The drug is expected to be available in the United States in the coming weeks

TV10 Editorial Staff